Skip to main content
Pharmena S.A. logo

Pharmena S.A. — Investor Relations & Filings

Ticker · PHR ISIN · PLPHRMN00011 LEI · 259400RHT936BBKW0955 WAR Manufacturing
Open in API
Filings indexed 649 across all filing types
Latest filing 2022-03-31 Audit Report / Informat…
Country PL Poland
Listing WAR PHR

About Pharmena S.A.

https://www.pharmena.eu/

Pharmena S.A. is a specialty healthcare company focused on the development and commercialization of innovative products based on its patented active ingredient, 1-MNA. This molecule is a naturally occurring metabolite of niacin (vitamin B3) that plays a crucial role in cellular metabolism. The company's technology leverages the ability of 1-MNA to optimize the levels of the coenzyme NAD+, which decline with age and are vital for cellular function and regeneration. The product portfolio includes specialized cosmeceuticals, such as the Dermena line for hair loss, and dietary supplements designed to address the effects of cellular aging.

Recent filings

Filing Released Lang Actions
Informacja zarządu ws wyboru audytora za 2021
Audit Report / Information Classification · 95% confidence The document is a formal declaration ('INFORMACJA ZARZĄDU') from the Management Board of PHARMENA S.A. dated March 31, 2022. The content specifically addresses the entity authorized to audit the financial statements ('podmiot uprawniony do badania sprawozdań finansowych') for the year 2021, confirming compliance with legal and ethical standards regarding the audit firm (PKF Consult Sp. z o.o. Sp. k.). This type of declaration, focusing on the auditor's qualifications and appointment, is a specific component often found within or accompanying the annual audit process, but it is not the full Annual Report (10-K) or the comprehensive Audit Report (AR). It is a specific regulatory disclosure related to the audit process. Given the options, it most closely aligns with Audit Report / Information (AR) as it directly concerns the audit function and compliance, although it is a statement *about* the auditor rather than the audit opinion itself. However, since it is a formal statement regarding the auditor selection and compliance, and not a general ESG or Management Discussion, AR is the best fit among the specific choices, as it relates directly to the statutory audit requirements. FY 2021
2022-03-31 Polish
Oświadczenie zarządu jednostkowe sprawozdanie za 2021 - podpis
Regulatory Filings Classification · 95% confidence The document text consists entirely of XML Digital Signature blocks (specifically XAdES signatures, indicated by the presence of xmlns:ds and xmlns:xades). These signatures contain metadata about the signing process, certificates, and references to an external file named "Pharmena_oswiadczenie_zarzadu-jedns_2021.xhtml". The presence of "oswiadczenie zarzadu" (management statement/declaration) in the referenced filename, combined with the fact that the document itself is just the signature block and not the content of the statement, suggests this is an attachment or supporting metadata for a primary filing. Since the content is purely technical metadata (digital signatures) and not the actual financial report, management discussion, or earnings release, it does not fit neatly into the primary content categories (10-K, ER, IR, MDA, etc.). The most appropriate fallback category for miscellaneous regulatory/technical attachments that don't fit elsewhere is Regulatory Filings (RNS). The document length is short (under 10,000 characters) and it is clearly metadata supporting another document, which aligns with the spirit of RNS or RPA, but RNS is the broader regulatory fallback.
2022-03-31 Polish
Oświadczenie zarządu jednostkowe sprawozdanie za 2021
Audit Report / Information Classification · 95% confidence The document text is very short (890 characters) and contains Polish text titled 'OŚWIADCZENIE ZARZĄDU W SPRAWIE RZETELNOŚCI SPORZĄDZENIA SPRAWOZDANIA FINANSOWEGO' (Management Board Statement on the Reliability of the Financial Statement Preparation) and 'SPRAWOZDANIA ZARZĄDU Z DZIAŁALNOŚCI' (Management Board Report on Activities). This is a formal declaration by the management board regarding the accuracy and truthfulness of the financial statements and the management report for the period ending 31.03.2022. This content is a component typically found within a comprehensive annual report (10-K) or an interim report (IR), but the document itself is just the management's assertion, not the full financial statements or the full management discussion and analysis (MDA). Given the content focuses specifically on the management's assessment of the financial reporting quality, it aligns most closely with the 'Management Reports' (MDA) definition, which covers management's explanation of results and outlook, or potentially an 'Audit Report / Information' (AR) if it were a standalone assurance document. However, since it is a direct statement from the management board about the financial statements' reliability, it fits best under MDA, which covers management's detailed explanation/assessment, or potentially as a component of the annual filing disclosures. Given the explicit focus on the 'Sprawozdanie Zarządu z działalności' (Management Report on Activities), MDA is the most appropriate fit among the provided options for this specific management assertion document. Q1 2022
2022-03-31 Polish
Sprawozdanie Audytora z badania jednostkowego sprawozdania finansowego za 2021 - podpis
Audit Report / Information Classification · 98% confidence The provided document text consists entirely of XML digital signature blocks (Signatures, SignedInfo, SignatureValue, KeyInfo, X509Data, etc.). This structure is characteristic of a digitally signed document, often used to ensure the integrity and authenticity of an official filing. The reference URI points to a file named 'Spraw_z_bad_mssf_jed_2022-03-31_pl.xhtml', and the signing time is March 31, 2022. The presence of 'Spraw z badania' (Audit/Review Report in Polish) strongly suggests an Audit Report or related information. Since the text provided is only the signature block and not the content of the report itself, and given the specific reference to an audit/review ('Spraw z bad'), the most appropriate classification is Audit Report / Information (AR). It is not an RPA because it is not announcing a report; it is the signed artifact itself, which falls under the scope of the report type it validates. Q1 2022
2022-03-31 Polish
Sprawozdanie Audytora z badania jednostkowego sprawozdania finansowego za 2021
Regulatory Filings Classification · 85% confidence The provided document text is extremely short ("Raport • • • - - - - - - - - - - - - - - - - - - - - - - - - • • • •") and contains only the word 'Raport' (Report in several languages) and separators. Given the minimal content and the 'MENU VS MEAL' rule, this is highly likely to be an announcement *about* a report rather than the report itself. Since it doesn't specify the type of report (like earnings or annual), the most appropriate general classification for a brief announcement of a filing or report is 'Regulatory Filings' (RNS) as a fallback, or potentially 'Report Publication Announcement' (RPA). Given the ambiguity and brevity, RNS is the safest general regulatory fallback.
2022-03-31 Dutch
Sprawozdanie z działalności za 2021 - podpis
Audit Report / Information Classification · 95% confidence The document text consists entirely of XML digital signature blocks ('Signatures', 'SignedInfo', 'SignatureValue', 'KeyInfo', 'X509Certificate', etc.). The content references a file named 'Pharmena_Sprawozdanie_z_dzialalnosci_2021.xhtml' and includes signing times from March 31, 2022. The Polish phrase 'Sprawozdanie z działalności' translates to 'Report on Activities' or 'Annual Report/Activity Report'. Since the document itself is just the signature metadata and not the actual report content, and it pertains to an annual activity report for 2021, it is most likely an attachment or metadata accompanying a formal filing. However, given the specific reference to 'Sprawozdanie z działalności 2021' (Activity Report 2021), and the fact that the document length is substantial (9973 chars), it is more likely the core content of a formal report, even if presented in a signed XML wrapper, rather than a simple announcement (RPA/RNS). In the context of Polish regulatory filings, a 'Sprawozdanie z działalności' often corresponds to the Annual Report (10-K equivalent) or a comprehensive Audit Report (AR). Since it is a 'Report on Activities' for a full year (2021), it strongly suggests the Annual Report category (10-K). If it were a quarterly report, it would likely be labeled as such. If it were purely an audit opinion, AR would fit, but 'Sprawozdanie z działalności' is broader. I will classify it as 10-K based on the annual nature implied by the filename and content context, assuming the XML structure is just the container for the report. FY 2021
2022-03-31 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.